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ABSTRACT
Purpose of the state-of-the-art review: Left ventricular (LV) global longitudinal strain (GLS) is recently recognized as a more sensitive measure of LV 
myocardial systolic function compared with LV ejection fraction (LVEF). In addition, left ventricular GLS , myocardial performance index (MPI) and 
maximum rate of LV pressure rise during isovolumetric contraction (LV dP/dtmax) are more reproducible than traditional assessment of LV systolic function 
by two dimensional echocardiography (2DE) LVEF. These underutilized techniques can detect preclinical myocardial dysfunction in patients who are at 
risk of LV failure in valvular-induced heart disease . Current guidelines for diagnosis and treatment of valvular heart disease (VHD) include LVEF as one 
of the parameters to take into consideration in the clinical decision-making. However, a large body of evidence has shown that left ventricular GLS, MPI 
and LV dP/dtmax have been classically considered as a sensitive marker of LV contractility and inotropic state. In turn GLS and myocardial performance 
may be a better prognosticator than LVEF in aortic and mitral valve heart diseases. This timely state-of-the-art review, appraised the evidence and role of 
GLS, MPI and dP/dT as clinical tools in patients with aortic and mitral valve disease. 
Recent findings: Left ventricular GLS has been shown to be prognostic in low-flow, low-gradient severe aortic stenosis with preserved LVEF. The role of 
left ventricular GLS, Tei index (MPI) and maximum rate of LV pressure rise (LV dP/dtmax) in patients with aortic regurgitation and mitral valve diseases 
(regurgitation and stenosis) is less well established.
Summary: Echocardiography is considered the primary non-invasive imaging tool for valvular heart disease assessment and the cornerstone method 
in diagnosing and evaluating the morphology and severity of aortic and mitral valve diseases. Currently, diagnostic-cardiac catheterization is no more 
recommended except in very rare cases when echocardiographic image quality is suboptimal, non-diagnostic and when the results of 2DE are discrepant 
with clinical data. Once clinical decision-making is based on the 2DE and three dimensional echocardiographic in assessment of the severity of mitral 
and aortic valve diseases, it is crucial that standards should be adopted to maintain accuracy and consistency across echocardiographic laboratories. This 
illustrative review article assesses left ventricular systolic function (LVEF) employing two and/or three dimensional echocardiography in comparison to 
GLS, MPI and LV dP/dtmax, especially applied for aortic valve (AV) and mitral valve (MV) diseases. It is noteworthy that this document only provides 
echocardiographic standards rather than making recommendations for clinical management. 
Conclusion: It is concluded that GLS, MPI and maximum rate of LV pressure rise during isovolumetric contraction (LV dP/dtmax) are recommended and 
more so, they should be increasingly used to identify subclinical LV myocardial dysfunction in patients with mitral and aortic valve heart diseases, to identify 
optimal timing for surgery and prognosticate outcomes after surgery.
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Introduction 
Echocardiographic Techniques for Strain Assessment 
Tissue Doppler imaging (TDI) or speckle tracking echocardiography 
(STE) is used to measure myocardial deformation. TDI was 
the first echocardiographic technique for obtaining strain 
measurements. It has been well validated and has the highest 
temporal resolution among all deformation imaging modalities 
[1,2]. However, the necessity of additional image acquisitions 
and post-processing for a comprehensive LV analysis are major 
limitations for routine clinical application. The newer approach, 
based on tracking speckles from frame to frame in the regular 
gray scale image, enables a fast and user-friendly semi- or fully-
automatic strain analysis, which can improve its usefulness in 
clinical practice. However, STE depends on good image quality 
and geometry, which limits its applicability in patients with 
suboptimal echogenicity. Recently , algorithm-related inter 
vendor differences have been substantially reduced following 
efforts of the European Association of Cardiovascular Imaging, 
American Society of Echocardiography and Industry Task Force 
on strain standardization [2]. Current studies suggest that STE 
might identify asymptomatic patients with severe aortic stenosis 
who would benefit from earlier intervention than recommended 
in recent guidelines [2,3]. 
The problems with image quality, frame rate, and inter vendor 
differences are even more pronounced in 3D STE compared with 
2D STE [4-6]. 
Assessing Cardiac Function in Valve Disease : Lv Ejection 
Fraction Versus Strain (Gls)
LVEF is incorporated into current guideline-recommended 
treatment strategies for valve diseases, in order to perform 
interventions in asymptomatic patients with severe valvular 
dysfunction before developing irreversible LV damage [7]. 
Therefore, surgery is recommended in a symptomatic patient with 
severe mitral regurgitation (MR) with early signs of LV systolic 
dysfunction (LVEF ≤60% and/or LV end-systolic diameter ≥45 
mm). Treatment is recommended at LVEF < 50% in patients with 
severe aortic regurgitation or aortic stenosis. However, assessment 
of systolic dysfunction in valvular heart disease is challenging. 
Furthermore, longitudinal strain has been shown to be a strong 
predictor of all- causes of mortality independent of aortic stenosis 
severity and EF or other known predictors [8].
LVEF represents only a relative volume change from end-
diastole to end systole and does not account for the complexity 
of myocardial mechanics and varies in response to pre load and 
after load changes. This volume-based parameter (LVEF) has 
an important limitation in reflecting systolic function in altered 
loading (pressure and volume) conditions, which are permanently 
present in patients with valve diseases. LVEF is often in the 
“supernormal” range in aortic and mitral incompetence lesions 
and therefore a poor representative of systolic myocardial function 
[9,10]. 
In summary, although GLS is of crucial importance in early 
detection of sub clinical LV myocardial dysfunction and predictive 
of all-cause mortality independent of aortic stenosis severity and 
ejection fraction. 2DE dimensions (end systole and end diastole LV 
dimensions) and systolic function indices (LVEF) and fractional 
shortening (FS) are still considered essential in determining the 
timing of surgery in aortic and mitral valve disease.
In mitral regurgitation, LVEF overestimates cardiac function as 
it reflects both the aortic forward stroke volume and regurgitant 
volume pumped into the low pressure left atrium. Consequently, 
LVEF can remain in a normal range for a long time and may mask 
subtle early reductions in contractility, despite intrinsic myocardial 
dysfunction [10].
In aortic valve (AV) stenosis (and pulmonary valve) lesions, 
present with concentric remodeling with increased wall thickness 
and reduced cavity diameter; hence LVEF can remain preserved 
despite reduced shortening of the myofibrils [10,11]. Therefore, 
LVEF can only detect LV systolic dysfunction in a relatively 
advanced stage of disease when a relevant myocardial contractile 
dysfunction has already developed. Myocardial deformation 
imaging, however, may be superior in detecting subtle dysfunction 
[9-11]. Longitudinal LV strain (GLS) is the most vulnerable 
component of LV mechanics. In an early stage of disease, impaired 
longitudinal deformation is often compensated by an augmented 
circumferential function, which keeps the LVEF within a normal 
range [11,12]. It has been shown that circumferential strain 
contributes more than twice as much to LV as longitudinal strain. 
Therefore, detection of early cardiac dysfunction in valve disease 
is one of the most promising indications of strain imaging [13-17].
Myocardial Performance Index (Tei Index) and Maximum 
Rate of LV Pressure Rise (LV dP/dtmax)
In addition to GLS and LVEF; a large body of evidence is now 
emerging highlighting the accurate assessment of LV and right 
ventricular contractile functions are possible in advanced aortic and 
mitral valve diseases at subclinical stage. Myocardial performance 
index (Tei Index) > 0.42 with increased B type natriuretic peptide 
(BNP) levels > 550 pg/ml  and depression of maximum rate of LV 
pressure rise LV ( dP/dtmax)  are better alternatives to LVEF in the 
presence of mitral and aortic valves regurgitation , for sub clinical 
detection of LV myocardial dysfunction [18-24,25].
Early studies showed that dP/dtmax  and MPI could Identify latent 
systolic dysfunction of LV and post-operative risk in patients 
with mitral and aortic valve diseases, even when LVEF was still 
preserved [18-23,25]. 
The Crucial Role of Echocardiography and Novel Parameters 
of LV Function Assessment in a Special Sub Groups of Patients 
With Valvular Heart Diseases 
Aortic Valve Stenosis (AS): Discordance Between Velocity And 
Aortic Valve Area (AVA) : Low flow AS, paradoxical low flow 
AS, associated aortic valve regurgitation (AR), hypertrophic 
cardiomyopathies (HCM) and arterial Hypertension (HTN) ,all 
can interfere with proper assessment of AS severity.
The role of Dobutamine-Induced Stress chocardiography (DSC) 
for Evaluation of as Severity in the Setting of LV Dysfunction. 
The findings which are highly suggestive of severe stenosis is an 
increase of the mean gradient to >30–40 mm Hg or a jet velocity 
≥ 4.0 m/s provided that valve area does not exceeding 1.0 cm2 
at any flow rate [26]. On the other hand , an increase in effective 
aortic valve area (AVA) to a final valve area >1.0cm2 suggests that 
stenosis is not critically severe [27]. Furthermore, increase in SV 
by > 20% from baseline suggests presence of contractile reserve 
, which has important clinical and therapeutic implication in low 
flow AS . Alternatively, absence of contractile reserve is a predictor 
of a high post-operative mortality and poor long-term outcome 
[28]. Another important application of DSE is an association of 
valvular AS with coronary artery disease (CAD) which can be 
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seen in up to 50% in elderly AS patients. An improvement of contractility of either a kinetic-hypokinetic or dys-synergic myocardial 
segment or biphasic response during DSE is considered as a sign of viability even if the ischemic myocardium is in jeopardy.
Figure 1: (A) Dobutamine Stress Echocardiography (DSE)  : The role of DSE  in the diagnosis of Low Flow Aortic Stenosis. The 
images in figure 1 (A) Show different acquisitions during DSE (Parasternal LAX, Apical 4 chamber view, Apical 2 chamber and 3 
chambers views).(B) 2D Strain, GLS generated from apical 3 projection, which was taken at peak stress during of DSE. Protocol  for 
uses a low-dose protocol, starting at 5 lg/kg/min with an incremental increase every 3 min to a maximum dose of 10–20 ug/kg/min. 
Once positive result is obtained (more than 20% increase in stroke volume (SV)), or an increase in AS jet velocity ≥4.0 m/s and a mean 
gradient (≥30–40 mm Hg), then the infusion should be stopped provided that valve area does not exceed (1.0 cm2) at any flow rate. 
It is very important to be very cautious and terminate immediately the dobutamine infusion  when significant tachycardia happened 
(rise of heart rate more than 20 beat per minute over baseline), or when hypotension, or significant ventricular or supraventricular 
arrhythmias and symptoms occur. Doppler data are recorded at each stage and the report of the DSE study should include LVOT 
diameter, AS velocity, mean gradient, SV and valve area at each stage. LVEF should be measured at base line-resting state and peak 
effect.   (Taken from reference (26 and 39)).
Low Flow, Low Gradient As With Preserved Ejection Fraction 
(Paradoxical Low Flow As)
The echocardiographic assessment of the severity of aortic valve 
stenosis (AS) usually relies on three main parameters including 
peak velocity, mean pressure gradient (MPG) and AVA, which 
should be concordant in the majority of aortic valve disease cases. 
In up to 20-30% of patients, these parameters are discordant ( AVA 
<1 cm² , AV velocity < 4.0 m/s and MPG <40 mmHg). In most 
cases, these patients present with a stroke volume index ≥35/ml/
m² (average normal flow). For better assessment of these patients, 
direct visualization of AVA by trans esophageal echocardiography 
(TEE) and calcium score should be measured using computed 
tomography (CT) which could be of great help in these category 
of patients. Intervention is recommended in symptomatic patients 
with proven severe AS and low gradient, as for patients with 
classic severe AS [29, 30]. The sub-group of ‘paradoxical’ low 
flow, low gradient AS with preserved EF refers to patients with 
left ventricular hypertrophy (LVH) resulting in reduced trans 
valvular flow ( SV index <35mL/m2 ) despite normal LVEF [30].
The most demanding area in clinical setting is AVA <1 cm2 with 
a lower peak velocity of <4 m/s and a MPG <40 mmHg despite 
normal LVEF. However, technical errors in AVA calculation (as 
LVOT diameter measurements) have to be carefully excluded, 
before the definite diagnosis of paradoxical low flow severe AS 
with preserved LVEF. Severe low flow low gradient AS with 
preserved LVEF has been described typically in elderly patients 
with LVH (small volume) and associated with Doppler and tissue 
Doppler evidence of LV diastolic dysfunction. In addition, reduced 
LV global longitudinal systolic strain (GLS) and fibrosis have 
been found in many cases. However, the majority of these patients 
had a history of long standing arterial hypertension that may 
also have caused the LV remodeling (hypertrophy and fibrosis) 
[29,30]. Importantly, diastolic function indices should be initially 
assessed non-invasively by conventional mitral Doppler flow, 
tissue Doppler imaging (TDI), filling pressure left atrial pressure 
(E/Ea) and pulmonary venous flow pattern.
Currently, it remains difficult in distinguishing between pseudo 
severe and true severe AS in clinical settings. The degree of valve 
calcification assessed by non-contrast CT may in this situation be 
an important hint to identify true severe AS [31]. However, only 
a high calcium score can ascertain severe AS while a low score 
makes severe AS highly unlikely. Moreover, careful follow up 
and reevaluation of symptomatic patients are recommended. In 
severe paradoxical low flow AS with preserved LVEF, patients 
are usually characterized by extensive LV concentric remodeling 
leading to a small LV cavity, restrictive LV filling pattern, and 
reduced systolic longitudinal myocardial shortening. 2DE by 
using conventional transthoracic approach (TTE) can be able 
to identify clearly the LV remodeling and different forms of 
hypertrophic cardiomyopathies in association with low-flow AS 
[32]. Similarly to the previous studies, the investigators found 
that echocardiographic calculation of AVA is highly dependent on 
accurate measurement of the diameter of the LVOT. To confirm 
the severity of AS, TEE should be used to measure the MPG, peak 
velocity and facilitate direct AVA planimetery area measurement 
in patients with poor TTE images, [33].
In patients with a valve area<1.0 cm2 with low MPG (< 40 
mmHG) and a velocity <4 m/s further classification based on the 
combination of velocity (gradient), trans valvular SV, and LVEF.
2DE and 3DE can also underestimate SV measurements which 
depend on LV end-diastolic, end-systolic volumes and LVOT 
geometry. Accordingly, multiple alternative approaches are 
recommended for calculation of SV index in clinical practice. 
Furthermore, there is an explanation for the low flow state which 
is most often due to a small ventricles with LVH and small LV 
volumes or LV systolic dysfunction with a reduced LVEF. In 
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clinical decision-making, the diagnosis of severe AS requires 
a number of multidisciplinary approaches. These include (a) 
Clinical judgment such as the symptoms of the patients, (b) 
Imaging of valve anatomy and morphology with proper LVOT 
measurement using 2DE, 3DE, TEE and CT, (c) Illustrative 
evaluation of haemodynamic parameters employing Doppler 
results such as MPG, SV and velocities, (d) LV morphology 
assessment (remodelling) and proper evaluation of LV systolic 
function including LVEF, GLS, MPI and LV dP/dtmax ) and (e) 
diastolic function indices such as conventional Doppler velocities, 
TDI and pulmonary venous flow pattern [32, 34]. 
Although, the AS velocity and mean gradient may be lower than 
expected for a given valve area (low flow AS) in the presence of 
a small hypertrophied LV (which ejects a small SV), even when 
severe AS is present. Continuity-equation valve area is accurate 
and indexed AVA is of great help in this situation (indexing valve 
area to body size). 
Assessment of the Left Ventricular (LV) Morphology and 
Function in AS 
LVH and changes in LV function in response to AS are important 
for AS grading and the definition of the pathophysiological stage 
of disease. Similarly, LV remodeling and myocardial dysfunction 
caused by concomitant disease such as arterial hypertension 
(HTN), coronary artery disease (CAD) and cardiomyopathy may 
significantly affect AS assessment. These associated diseases can 
affect both LV systolic and diastolic functions which could reduce 
the SV / SV index and pressure-gradient in AS. It is important 
to emphasize here, that GLS by STE can differentiate between 
normal, ischemic-although viable (myocardial hibernation) and 
scarred or infarct myocardium in a quantitative manner. A Multi-
Centre trial is a pre-request before clinical application can be 
considered for scar-infarct. This can only be done once GLS 
shows systolic lengthening or zero systolic strain as well as an 
ischemic–viable myocardium which displays only a depressed 
systolic strain value. One important conclusion that emerges from 
the previous studies reviewed in this paper is that quantitative 
assessment of LV myocardium remodeling is an essential tool for 
integrating the wealth of information required to understand this 
complex system. The information can also help in predicting the 
impact of novel diagnostic modalities and proper therapies on a 
dysfunctional myocardium which undergoes remodeling following 
either myocardial infarction or left ventricular hypertrophy in AS 
hypertensive patients.
Conventional Parameters of LV Function Assessment
Conventional parameters of LV function include the measurement 
of LV dimensions at end-diastole and end-systole providing 
fractional shortening (FS) and end-diastolic and end-systolic 
volumes providing LVEF and SV. Because LVEF is load dependent, 
the increase in LV afterload in the presence of severe AS may result 
in apparent depression of LV systolic function indices which is 
manifested by low LVEF (measured by conventional 2DE) despite 
preserved LV myocardial function . So, correction of this afterload 
mismatch by AV replacement could improve LVEF and FS after 
relief of obstruction. 
New Insight in the Assessment of LV Function In Paradoxical 
Low Flow As With Normal Ef Associated With Novel 
Parameters of LV Function Assessment 
Alternative to LVEF, the following techniques are able to assess LV 
contractile function accurately in aortic and mitral valve diseases 
in patients with normal LVEF:- 
i. Mitral annular displacement by tissue Doppler Imaging (TDI) 
ii. Global Longitudinal Systolic Strain (GLS) 
iii. Myocardial Performance index (MPI) or (Tei Index) .
iv. BNP levels 
v. Doppler-derived rates of left ventricular pressure rise and fall 
(dP/dt and –dP/dt) 
In this State-Of-The-Art Review, It is Relevant to Focus on 
the Update in GLS, MPI and dP/dt.
Global Longitudinal Strain (GLS) 
In severe AS, GLS measurements are able to detect sub clinical 
impairment of LV myocardial systolic function when EF is still 
normal and may predict prognosis in many studies [3,8,35-37]. 
In patients with aortic stenosis, GLS progressively worsens 
with increasing disease severity (from −18.2±2.1% in mild to 
−13.3±3.7% in severe aortic stenosis) [3]. Longitudinal strain 
has been shown to be a strong predictor of all-cause mortality 
independent of stenosis severity and LVEF or other known 
major risk factors of CAD and predictors of HF [37,38]. The 
observed changes in the shape and size of cardiac myocytes 
are considered cardiac remodeling, which are known to explain 
cardiac dysfunction in heart failure but may be physiological. 
These pathophysiological markers of pre heart failure (PHF) 
could be examined via GLS and other myocardial strains [32,37]. 
In clinical practice, GLS and area strain have been shown to 
be more reproducible and more useful compared to radial and 
circumferential strains. They have been demonstrated to be as 
accurate as son micrometry and magnetic resonance imaging 
(MRI) in several conditions related to cardiovascular diseases. 
2D and 3D speckle tracking echocardiography have been used to 
quantify regional alterations of longitudinal strain and area strain 
through their polar projection, which allows a further evaluation 
of the exact site and extent of myocardial damage that may be 
important in clinical decision-making [37,38]. Furthermore, 
2D and 3D speckle tracking echocardiography can overcome 
certain limitations in conventional 2DE in the assessment of 
cardiac function in AV disease [36,39] . Importantly, there is an 
evidence of negative Impact of myocardial fibrosis in patients 
with symptomatic severe AS which is associated with un 
favorable outcomes and may be reflected in reduced GLS [32,40-
43]. However, certain limitations to the clinical utility of GLS 
include some degree of afterload dependence and inter-vendor 
differences in strain measurements [4,44]. Although, the role of 
GLS in a symptomatic AS for the detection of preclinical stage 
of myocardial dysfunction is well defined, its clinical application 
as a parameter that may decide timing of intervention remains 
insufficiently defined. Nevertheless, GLS can be used as an 
additional imaging technique within an integrated approach to 
assess AS severity and its impact on LV myocardial function, 
in many occasions in selected patients as in (a) Paradoxical low 
flow severe AS with preserved LVEF , (b) Severe mitral and 
aortic valve incompetence lesions and in (c) Arterial hypertension 
in association with LVH . Interestingly, an excessive LVH as 
assessed by 2DE has been shown to be a predictor of outcome 
[45]. Although, accurate assessment of LV myocardial fibrosis is 
definitely requires cardiac MRI with late Gadolinium. A recent 
meta-analysis study [46] demonstrated that in a symptomatic 
patients with 2DE evidence of severe valvular AS and normal 
LVEF, impaired left ventricular GLS is associated with high 
mortality. These data emphasize the potential usefulness of LV 
GLS for risk stratification and early management of these patients. 
This meta- analysis included 1,067 a symptomatic patients with 
significant AS and LVEF >50% were analyzed. The median of LV 
GLS was -16.2% . There were 91 deaths reported during follow-
up with median of 20 Months, resulting in a pooled mortality 
rate of 8.5%. The LV GLS performed well in the prediction of 
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death .The best cut off value identified in this study was LV GLS 
of -14.7%. Random effective models have been employed in 
this meta-analysis and they demonstrated that the risk of death 
for AS patients is significant at LV GLS <14.7%; p < 0.0001).
Interestingly, the relationship between LV GLS and mortality 
remained significant in patients with normal LVEF (≥60%), p = 
0.001. Similarly, Lancellotti et al [41] examined a cohort of 163 
patients with at least moderate to severe, a symptomatic AS. They 
demonstrated that impaired GLS was an independent predictor 
of survival. Those patients with GLS >15.9% had significantly 
better outcome than patients with the strain less than 15.9% (4-
year survival of 63% vs. 22%, P < 0.001). Interestingly, a recent 
publication in 2020 conducted by Elkilany et al [47], illustrated 
a concomitant dilated cardiomyopathy which was observed in 
1.8% of subjects with bicuspid aortic valve (BAV). A few different 
clinical and echocardiographic characteristics were found. They 
concluded that, the presence of cardiomyopathy was independently 
associated with heart failure either clinically or at the sub clinical 
stage, which can be identified by global systolic strain at the 
preclinical stage of the disease. Furthermore, there are increasing 
role of GLS in the diagnosis of subclinical systolic dysfunction-
and normal EF in arterial hypertension, CAD, HCM and valvular 
heart diseases. Different studies have described the crucial role of 
three dimensional strain and 2D strain for detection of subclinical 
LV dysfunction and normal EF in hypertensive patients with an 
associated AS and paradoxical low flow-low gradient and severe 
AS. In addition, the presence of diastolic dysfunction (grade II-IV) 
and high left atrial pressure by conventional Doppler and TDI (Ea 
< 8 cm/s, E/Ea >14), can clearly point to the mechanism(s) of low 
flow and low gradient AS with preserved EF [45-46].
Figure 2: This figure illustrates the role global longitudinal systolic strain (GLS) in the diagnosis of subclinical systolic dysfunction-
and normal EF in arterial hypertension. (A) shows 3D Strain and (B) shows 2D Strain for detection of subclinical LV dysfunction 
and normal EF  (GLPSS-13%), in hypertensive patient with low GLS in AS patient with paradoxical low flow- low gradient  severe 
AS.  The image in (C) shows grade III/IV diastolic dysfunction by conventional Doppler flow and the image in (D) shows evidence 
of diastolic dysfunction by tissue Doppler imaging (Ea< 5 cm/s). Permission for the images was given by the corresponding author 
Dr. GEN Elkilany and from Dr. Bernhard Mumm, CEO Tom Tech Company, Germany.
In summary, the diagnosis of severe AS in clinical practice 
must be based on multidisciplinary and an integrated approach 
including : (i) Doppler assessment of trans-valvular velocity/ 
gradient,(ii) AVA (iii) Imaging of valve morphology,(iv) Proper 
assessment of flow rate and stroke volume (SV) (v) Evaluation 
of LV morphology (remodeling and LVH), (vi) Measurements 
of LV systolic and diastolic function indices by 2DE , TDI and 
GLS, (vii) Accurate measure of blood pressure level and finally 
(viii) Clinical assessment of the symptomatic status . Accordingly, 
it is essential in clinical settings to use an integrative approach 
when grading the severity of AS, combining all Doppler and 
2DE data as well as clinical presentation, and not relying on one 
specific parameter. Optimization of loading conditions (arterial 
hypertension and high cardiac output states) which influence 
velocity and pressure gradients are crucial and therefore, these 
parameters which vary depending on illness of patients with low 
versus high cardiac output, should be considered in evaluation 
of valve disease severity. In addition, cardiac arrhythmias or 
tachycardia can interfere with proper Doppler assessment of 
AS severity. Consequently, hemodynamic assessment should 
be performed at an average blood pressures and heart rate levels 
within the normal range. 
In conclusion, the implication of cardiac ultrasound with routine 
use of GLS is a must for early detection and proper management 
of cardiac dysfunction in a symptomatic AV disease patients and 
this is reasonably recommended in BAV and AS with concomitant 
AR [47]. 
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Myocardial Performance Index (MPI) 
Doppler-derived myocardial performance index (MPI) has been 
considered as a diagnostic and prognostic Doppler marker for many 
different clinical conditions. Tissue Doppler imaging MPI and 
Pulsed wave Doppler MPI were significantly higher in patients with 
grade I diastolic dysfunction than in control subjects: 0.49 ± 0.14 vs. 
0.40 ± 0.09 (P < 0.001) and 0.45 ± 0.11 vs. 0.37 ± 0.08 (P < 0.001), 
respectively. Cutoff values of TDI-MPI > 0.42 and pulsed wave 
Doppler (PWD)-MPI > 0.40 identified grade I diastolic dysfunction 
subjects, with good sensitivities and specificities in a recent study 
conducted by Jose M. et al [48]. Recently, Redfield et al studied 
the burden of systolic and diastolic ventricular dysfunction and 
demonstrated that, an initial diastolic dysfunction detected by 
Doppler echocardiography was an independent risk factor for the 
development of heart failure (HF) and all-cause mortality, even in 
a symptomatic patients [49]. The myocardial performance index 
(MPI) or Tei-Index, described more than a decade ago, has been 
well documented in the literature as a prognostic marker and can 
predict the progression of various cardiovascular diseases [20,50]. 
However, in the majority of these studies, MPI was used in patients 
with combined systolic and diastolic dysfunctions. Furthermore, 
Liu D et al demonstrated recently, the great value of tissue Doppler-
derived Tei index and two-dimensional speckle tracking imaging 
derived longitudinal strain on predicting outcome of patients with 
light-chain cardiac amyloidosis [51].
An alternative for MPI calculation is the use of the pulsed-wave 
TDI-derived MPI, which allows simultaneous measurement of 
both the diastolic and systolic intervals in the same cardiac cycle, 
with high diagnostic accuracy in subjects with heart failure and 
LV myocardial dysfunction [52,53]. This new technique, can 
overcome the limitation of the conventional Doppler-derived 
MPI method which are based on flow-velocity curves and 
are performed in different cardiac cycles. An important study 
conducted by Johan and his colleagues [54] compared eight 
different echocardiographic and Doppler indices of cardiac 
function as predictors of congestive heart failure (CHF) using 
a population-based cohort of more than five hundred elderly a 
symptomatic men (without overt HF) and significant valve disease 
at baseline (median follow-up time 8.2 years). In a multivariable 
Cox proportional-hazard analysis including the different indices of 
cardiac function, high MPI, abnormal LV wall motion score index 
and diastolic dysfunction (a pseudo-normalized/restrictive- E/A-
ratio pattern) independently predicted future CHF morbidity. After 
adding traditional CHF risk factors (age, previous CAD, diabetes 
mellitus, arterial hypertension, hyperlipidemia, smoking, LVH and 
body mass index) to the above model, only a high MPI remained 
a significant predictor (p=0.002). The investigators concluded that 
MPI can provide an important prognostic information for the risk 
of future congestive heart failure, beyond other measurements of 
diastolic and systolic cardiac function indices and traditional HF 
risk factors in 70 years elderly men [52-54].
Aortic regurgitation (AR)
Up to 80% of adults with AS also have an associated mild 
or moderate AR. Although, measures of AS severity are not 
significantly affected in mild to moderate AR lesions. However, 
in severe AR and because of the increased trans aortic valve 
volume flow rate, maximum velocity and MPG will be higher 
than expected for a given valve area. In this situation, reporting 
accurate quantitative data for the severity of both stenosis and 
regurgitation is helpful for clinical decision-making[55,56]. 
Furthermore, velocity and mean gradient still remain the major 
predictors of outcome in combined moderate AS and moderate AR 
[55]. Aortic regurgitation patients with symptomatic moderate-to-
severe and severe aortic regurgitation have more impaired GLS 
than those without symptoms (−14.9±3.0% vs. −16.8±2.5%) 
respectively [57]. In asymptomatic patients, the risk of death 
continuously increases as GLS worsens [57]. In the same study, 
GLS significantly improved the reclassification of mortality 
risk and was independently associated with the need for aortic 
valve surgery in asymptomatic patients with moderately severe 
or severe aortic regurgitation and preserved LVEF [57, 58]. In 
patients undergoing aortic valve surgery, preoperative GLS worse 
than −19% was associated with reduced long-term survival after 
surgical procedure [59]. 
Figure 3: Images A-D show the different forms of Hypertrophic Cardiomyopathies that can be responsible of paradoxical low 
flow aortic stenosis with normal EF. Abbreviation, HOCM, hypertrophic obstructive cardiomyopathy , HD , heart disease , HHD, 
hypertensive heart disease.
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Mitral stenosis and right-sided valve diseases
Recent studies suggested that strain echocardiography might 
be useful to improve the assessment of myocardial function in 
valve diseases, particularly in detecting subclinical dysfunction 
and defining the timing of interventions. However, a majority 
of studies focused on aortic and mitral valve disease, while data 
on right-sided valve diseases are limited. Patients with severe 
mitral stenosis have reduced LV deformation which is related to 
the severity of mitral stenosis [60]. Improvement in strain values 
was detected within 72 hours after balloon mitral valvuloplasty 
of severe mitral valve stenosis. The potential prognostic value of 
right ventricular (RV) longitudinal strain was found in patients 
with significant tricuspid regurgitation [61]. Impaired RV free 
wall longitudinal strain (worse than −23%) was associated with 
worse outcome with a prognostic value beyond conventional 
echocardiographic parameters of RV systolic function. In patients 
with pulmonary valve disease undergoing percutaneous pulmonary 
valve implantation, pre interventional RV longitudinal strain can 
predict improvement of exercise function after intervention [62].
Mitral Regurgitation
In patients with severe primary mitral regurgitation undergoing 
interventions, preoperative GLS is an independent predictor of 
cardiovascular events and death and appears to have incremental 
predictive value over conventional clinical and echocardiographic 
risk factors [25,63- 66]. One of the largest studies revealed that 
mitral valve surgery in patients with a symptomatic severe mitral 
regurgitation was beneficial with respect to outcome (all-cause 
mortality), particularly in those with GLS worse than –21% [64]. 
In addition, preoperative GLS worse than -18.1% predicted post 
procedural LV dysfunction in patients undergoing mitral valve 
surgery [63]. Interestingly, the GLS reported in these studies was 
higher than what is considered the lower limit of normal, which 
indicates that strain values that are otherwise considered normal 
are already associated with impaired outcome in patients with 
primary mitral regurgitation. Large studies evaluating the clinical 
utility of strain in secondary mitral regurgitation are limited. 
Recently, a retrospective analysis of 650 patients with moderate 
and severe secondary mitral regurgitation demonstrated that GLS 
worse than −7.0% was associated with increased risk for all-cause 
mortality, whereas LVEF was not [67]. The lower GLS found 
in this study compared to those with primary regurgitation may 
be explained with specific high-risk patient population that was 
investigated. The study population mostly comprised of patients 
with advanced heart failure with a mean LVEF of 29±10%, half 
of which had an ischemic cardiomyopathy. 
Concomitant Mitral Regurgitation (MR) and Aortic Valve 
Disease 
MR is common in elderly adults with fibro calcific AS either 
as a consequence of increased LV pressure overload, or in 
association with concomitant mitral valve disease. These include 
in the following conditions : (i) Rheumatic heart disease, (ii) 
Degenerative etiology due to mitral valve calcification or extension 
of calcification from calcific aortic valve to mitral valve apparatus 
, (iii) Mitral valve prolapse, and (iv) Secondary MR etiologies 
(Ischemic MR and in dilated cardiomyopathy). 
It is crucial to use standard approaches and utilization of different 
echocardiographic projections to distinguish MR owing to a 
primary abnormality of the mitral valve from secondary MR 
related to increased pressure overload (secondary to AS).
Figure 4: This figure illustrates the process of ischemic etiology 
of pseudo severe AS which is associated with other causes of LV 
dysfunction such as myocardial infarction. Note that depressed 
strain values appear at the basal septal and basal anterior wall 
segments as represented in the ischemic –viable myocardium 
(pink in color-light red). Similarly, systolic lengthening and 0 
strain (blue in color) represent the infarct-scar at mid-antero-septal 
segments and apex proper of the left ventricle by GLS. These 
values are correlated to the regional wall motion abnormalities 
from hypokinetic to a kinetic myocardium respectively, at left 
anterior descending coronary artery (LAD). The territories are 
presented in 3 apical projections by 2DE. All rights reserved to 
the corresponding author , GEN Elkilany.
Critical Points in Assessment of the Severity of MR and 
AS in the Presence of Concomitant AS with MR (Clinical 
Perspectives):
a) Timing of the signal and configuration of the slope velocity 
are the most reliable way to distinguish the CW Doppler 
velocity curve of MR from AS. Moreover, MR is longer in 
duration, starting with mitral valve closure and continuing 
until mitral valve opening. AS jet is of crescendo decrescendo 
contour, started just after MV closure and terminates before 
the second heart sound in the majority of cases.
b) In severe MR, trans-aortic flow rate may be low resulting in 
a low gradient even when severe AS is present with valve 
area calculations remain accurate in this setting as long as 
flow is calculated in the LVOT. 
c) High LV pressure due to severe AS, may lead to MR 
severity overestimation .The high driving pressure will 
also disproportionately increase the MR volume for a given 
regurgitated orifice area.
d) Furthermore, it is essential for the clinical decision making to 
decide whether the mitral valve requires intervention in the 
setting of an associated aortic valve disease (AS) by careful 
evaluation of the mechanism (s) of MR and its severity. 
Evaluation of the grades of MR severity should include : (a) 
Effective regurgitant orifice area (EROA), (b) Regurgitant 
volume , (c) Regurgitant fraction (RF) and (d) Proximal 
isovelocity surface area (PISA) method [55,56, 68].
Arterial Hypertension (HTN)
Earlier studies described HTN which was accompanied AS in 
35–45% of patients. However, in elderly patients with low flow, 
low gradient AS, it was present in the majority of these patients 
[29,30]. The presence of HTN may primarily affect flow and 
gradients but far less AVA measurements. Impaired GLS in 
arterial hypertensive patients was detected in many studies with 
or without a concomitant MR or aortic valve diseases, although 
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the LVEF was still remaining at the normal range (> 50%) [32,64-
67]. Nevertheless, in uncontrolled severe arterial hypertension, 
the measure of grade of aortic valve stenosis severity may not be 
accurate (can make MPG and velocity changes) and will not reflect 
the exact AS severity [69-70]. Thus, control of blood pressure is 
a must before echocardiographic evaluation. 
Echocardiographic Predictors of Symptom Development and 
Adverse Outcomes in AS [3,7,71,72] 
The followings are the criteria that increase the likelihood of 
severe AS in patients with AVA<1.0 cm2 and mean gradient less 
than expected (<40 mm Hg) in the presence of preserved EF:- 
1. Clinical criteria:- Physical examination consistent with 
severe aortic valve disease , typical triad symptoms of (chest 
pain, syncope and dyspnea) without other explanation.
2. Qualitative imaging data:-The presence of otherwise 
unexplained LVH, reduced GLS without other explanation, 
an increased echo reflection (echo-dense aortic valve) due 
to extensive calcification, limited or no cusp motion and a 
decrease in the maximal aortic cusp separation in 2DE and 
M-Mode.
3. Quantitative multimodality imaging techniques (2DE , CW 
and PW Doppler , CT, cardiac MRI): Mean gradient 30–40 
mm Hg, AVA< 0.9 cm2 and low flow (SV index <35 mL/
m2) :- Low flow low gradient AS should be confirmed by 
other techniques than standard Doppler technique (LVOT 
measurement by 3D TEE or calcium score by CT, cardiac 
MRI or/and invasive data) .
A recent study revealed that a symptomatic patients with severe 
aortic stenosis undergoing treadmill stress echocardiography, lower 
LV GLS were associated with higher longer term mortality and 
offer incremental prognostic value [73]. Similarly, in symptomatic 
severe AS, either high-gradient or low-flow, low-gradient, 
preoperative GLS was associated with long-term postoperative 
cardiac mortality and morbidity in all therapeutic approaches in 
either surgical or trans catheter aortic valve replacement [74,75] 
. In a symptomatic severe AS and normal EF, a GLS worse than 
−18.2% has been shown to be associated with disease progression, 
evidenced by symptoms onset and need for valve intervention 
[76]. In a recent meta-analysis including 1067 patients, a GLS 
worse than −14.7% predicted occurrence of death with 60% 
sensitivity and 70% specificity and was associated with a >2.5- 
fold increased risk of death [77]. Interestingly, the Heart Valve 
Clinic International Database (HAVEC) group recommended the 
incorporation of GLS into therapeutic decision-making [78]. Thus, 
patients with a symptomatic severe aortic stenosis with GLS worse 
than −16.0% and other high-risk factors (high-calcium score on 
cardiac computer tomography and myocardial fibrosis detected by 
magnetic resonance) may be considered for intervention. A similar 
algorithm was recently proposed by Dahl et al. [79].
Figure 5: A Schematic diagram showing how to measure index 
of myocardial performance (MPI) : isovolumetric relaxation 
time(IVRT) , isovolumetric contraction time (IVCT) , LV ejection 
time (ET), MPI=  IVRT+IVCT/LVET.E, points to early mitral 
Doppler diastolic velocity ; A represent the  pre systolic-late mitral 
Doppler diastolic velocity filling pattern.
Maximum rate of LV Pressure Development (LV dP/dT ) : The 
Role in a Preclinical Detection of LV Myocardial Dysfunction 
in VHD 
The Doppler-derived rates of LV pressure rise(dP/dt) has important 
clinical implication.
Interestingly, a consensus published by Cecconi M. and his 
colleagues revealed that peak velocity of the early diastolic 
wave and rate of LV pressure drop (–dP/dt) were identified as 
independent predictors of CHF. The findings suggested that 
Doppler-derived dP/dt and –dP/dt, used in combination with 
conventional echocardiographic variables, could allow a better 
understanding of myocardial dysfunction and a possibility for 
prediction of the risk of heart failure in dogs with chronic mitral 
valve disease [80].
Furthermore, the investigators demonstrated that LV contractility 
(inotropic state of the left ventricle) is one of the main determinants 
of cardiac function and is considered as an important element 
of the hemodynamic evaluation of the critically ill patients 
[80]. LVEF was estimated by 2DE as the fractional area of 
contraction. However, LVEF has known limitations as an 
index of cardiac systolic (inotropic) function, such as the high 
dependency on the cardiac loading conditions [81]. Although 
new echocardiographic indexes, such as speckle-tracking-derived 
LV global longitudinal strain or strain rate, have been recently 
introduced, their need of sophisticated software, standardization 
of methodology and well trained operators preclude their use for 
continuous hemodynamic monitoring of the LV systolic function 
in critically ill patients. Alternatively, the maximum rate of LV 
pressure during isovolumetric contraction (LV dP/dtmax) has been 
classically considered as a marker of LV inotropic state [82,83]. 
Left ventricular dP/dtmax has been traditionally used as a reliable 
marker of myocardial performance [83, 84]. The maximal rate 
of LV pressure rise (+ dP/dtmax ) is usually developed during 
isovolumetric contraction under normal circumstances [84], 
so theoretically LV dP/dtmax should be relatively insensitive to 
afterload.
Advantages of Systolic Index of Contractility (DP/DT) 
The maximum rate of rise of LV pressure during the isovolumic 
contraction phase of LV systole, dP/dt(max) is considered a 
sensitive and good measure of LV contractility. This technique 
is not affected by afterload and very minimally influenced by 
preload [84]. The prerequisite for this measurement using 2D 
and Doppler echocardiography is that the associated mitral valve 
should have some degree of central mitral valve regurgitation 
(MR). In that case, the shape of the MR jet, which should be 
interrogated with a continuous wave Doppler (CWD) and the 
spectral display optimized, reflects the instantaneous pressure 
difference between the LV and LA during LV systole. 
In the presence of global LV dysfunction, the LV pressure buildup 
will decrease and the LA pressure will increase which will decrease 
the rate of rise of MR jet velocity. This is the principle behind 
this method of assessing global LV function. [64,84]. In order to 
calculate dP/dt(max), the time taken for the velocity to rise from 
1 m/s to 3 m/s during measurement by CWD (of MR jet during 
isovolumetric contraction phase) using the modified Bernoulli 
equation [64,84]. However, there are some limitations in clinical 
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application of dP/dt(max) which include the followings:- 
1. A good MR signal is mandatory which may not always be the 
case. Even eccentric jets which will not be optimally aligned 
to the CW Doppler are of no use. 
2. A small error in the time interval will produce a large change 
in dP/dt(max) value because we are dividing a large number, 
i.e., 32,000 by the time interval. 
3. This method is inappropriate in the presence of acute MR 
because of high left atrial pressures.
4. dP/dt(max) is not an entirely load-independent index of LV 
function.
Moreover, in the presence of LVH secondary to aortic valve 
disease , the speed of left-heart relaxation is impaired, but the 
peak rate of myocardial relaxation is unaltered. Abnormalities of 
LV systolic function have no direct bearing on relaxation, and the 
extent of LVH appears to be a determinant of left-heart relaxation. 
[85] However, for future studies, multimodality cardiac imaging 
techniques can be utilized for a proper assessment of cardiac 
function and patients at risk of heart failure at the preclinical stage 
of the disease [37,64,86].
Figure 6: (A) Bulls eye technique (automated function imaging algorithm), GLS generated from apical 2,3 & 4 chamber views 
illustrated the impaired global longitudinal peak systolic strain (GLS) of -13%  in hypertensive patient and significant mitral valve 
incompetence and AS, but normal ejection fraction (EF = 51%), (B) Shows severe AS in correlation to GLS in (A). (C) shows that 
maximum rate of max. LV positive pressure development ( MR+dp/dt), which is depressed in the same patient ( 645 mm Hg/s) . This 
figure also illustrates , how to measure  dp/dt , at 1st and 3rd m/seconds of MR CWD slope (Taken from reference [64]).
Table 1: Data showing LV function and the changes in dP/
dt(max) over time
LV function dP/dt   
(mmHg/s)
Normal >1200
Borderline 800-1200
Reduced <800 , severely reduced < 500
Conclusion
Echocardiographic strain imaging allows for new insight into a 
complex cardiac mechanics and enables more precise evaluation of 
cardiac function. Hence, it has been shown to have clinical utility 
in a variety of VHD. In particular, global longitudinal strain has 
been shown to be more sensitive to detect systolic dysfunction 
than left ventricular ejection fraction. Subclinical myocardial 
dysfunction that is characterized by impaired LV GLS is often 
present in patients with a symptomatic severe VHD and in severe 
AS with preserved LVEF. Left ventricular GLS further deteriorates 
over time and impaired GLS at baseline is associated with an 
increased risk for progression to the symptomatic stage and the 
need for aortic valve intervention in severe AS and AR patients. 
Similarly, depressed LV GLS in a symptomatic severe MR could 
identify high risk patients which could benefit from early mitral 
valve repair or replacement. Strain echocardiography and MPI 
in VHDs have been demonstrated to be a useful complementary 
echocardiographic method that can identify patients at risk of 
developing either symptoms or poor survival and might assist 
in therapeutic decision-making. In addition, MPI seems to be a 
clinically relevant monitoring of cardiac function and may prove 
to be a valuable tool in assessing the risk of future congestive HF. 
In patients with valvular heart diseases GLS can provide both 
diagnostic and prognostic information in addition to standard 
echocardiographic and clinical parameters. However, a profound 
understanding of the complex interaction between loading 
conditions, chamber geometry, and contractility is necessary for 
the correct interpretation of myocardial deformation in order to 
draw appropriate conclusions in patients with valve disease.
Finally, the maximum rate of LV pressure rise (LV dP/dtmax) 
has been traditionally used as a reliable marker of myocardial 
performance. Although a multicenter trials are required for a 
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potential use and clinical application of LV dP/dtmax , theoretically, 
LV dP/dtmax is relatively insensitive to afterload and therefore, it 
can be used as a sensitive method for myocardial contractility 
in patients with valvular heart disease . A prerequisite for this 
measurement using 2D and Doppler echocardiography is that the 
associated mitral valve should have some degree of central MR 
for proper assessment. 
Conflict of interest: None declared.
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